A clustered family history of breast, ovarian, and colon cancers appropriately triggered germline testing, with BRCA1 mutation status informing individualized risk stratification and counseling.

For women who undergo a mastectomy, reconstruction is treated almost as a given. We speaks to seven women proudly defying the status quo.

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in ...

Niraparib and abiraterone acetate regimen demonstrates clinically meaningful delay in disease progression, nearly halving the risk of progression or death, with an early trend toward improved overall ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients ...

Late in 2025, we covered the development of an AI system called Evo that was trained on massive numbers of bacterial genomes. So many that, when prompted with sequences from a cluster of related genes ...

A cancer drug class best known for attacking tumors may also help your immune system remember them better. Researchers at ...

Researchers at Memorial Sloan Kettering Cancer Center (MSK) have made an important discovery about how genetic mutations in breast cancer patients can interact and drive resistance to certain drugs ...

A new Australian artificial intelligence tool could transform breast cancer screening by offering a more personalised and ...

In a second EU approval today, Johnson & Johnson got a green light for Akeega (niraparib and abiraterone acetate) for the ...

The study found that low- and middle-income nations are more affected by breast cancer cases in comparison to high-income groups. To know what are some of the leading causes of breast cancer, read on.

An artificial intelligence (AI) algorithm used to detect breast cancer in screening scans has been adapted into a risk score ...